バイオ汚染除去の世界市場規模：製品タイプ別、薬剤別、エンドユーザー別、地域範囲別および予測

バイオ汚染除去の市場規模と予測

バイオ汚染除去市場規模は、2024年に1億4,983万米ドルと評価され、2026～2032年にかけてCAGR 4.22%で成長し、2032年には2億854万米ドルに達すると予測されています。

バイオ汚染除去は、微生物汚染を除去するか、許容レベルまで低下させるプロセスです。細菌の存在が深刻な健康被害をもたらす可能性のある様々な環境において、バイオ除染は非常に重要です。

バイオ汚染除去は、隔離室、重症治療室、手術室などの病院環境で、病原菌の感染を防ぐために行われています。

さらに、製品の純度と従業員の安全を確保するために、製薬会社やバイオテクノロジー会社でも利用されています。

バイオ汚染除去の世界市場力学

バイオ汚染除去市場を形成している主要市場力学は以下の通りです。

主要市場促進要因

ヘルスケア関連感染（HAI）の増加：HAIの増加がバイオ汚染除去市場の主要促進要因です。米国疾病予防管理センター（CDC）によると、病院患者の31人に1人が、1日に少なくとも1件のヘルスケア関連感染に罹患しています。このような高い発生率から、ヘルスケアの現場では、病気の蔓延を抑え、患者の安全を確保するために、堅牢なバイオ除染ソリューションが極めて重要であることが浮き彫りになっています。

製薬・バイオテクノロジー産業の成長：製薬産業とバイオテクノロジー産業の成長は、バイオ汚染除去サービスと製品に対する需要を高めています。FDAは、2022年に37の革新的な医薬品が承認されたと報告しており、産業の継続的な拡大と技術革新を実証しています。この増加は、無菌の産業環境と汚染制御方法に対する需要の増加に直結しており、バイオ除染市場を牽引しています。

厳しい規制基準：多くの産業で清浄度と無菌性に関する規制が厳しくなっていることが、バイオ汚染除去市場を牽引しています。例えば、欧州医薬品庁（EMA）は2024年8月にEU GMP Annex 1を施行し、無菌医療品の製造に関する詳細な規則を制定しました。この規則では、汚染防止対策の必要性が強調されており、先進的バイオ汚染除去技術とサービスの利用が奨励されています。

主要課題

高コスト：機器やインフラへの初期投資を含め、バイオ汚染除去技術やサービスのコストが高いため、特に資源に乏しい環境や発展途上国での導入が制限されています。このコストの障壁が、これらの重要な汚染除去方法の普及を妨げています。

認識の欠如：場所によっては、バイオ除染の重要性と利点に関する認識が不足しているため、導入率が低くなっています。エンドユーザーを教育し、清潔で衛生的な環境を保つことの重要性を強調することは、この制約を克服するために不可欠です。

病原体耐性のばらつき：異なる感染症の耐性レベルは、バイオ除染手順の有効性に影響し、一貫した正確な除染結果を確保することを難しくしています。このばらつきに対処することは、市場の継続的開拓に不可欠です。

主要動向

過酸化水素蒸気（HPV）技術の採用増加：HPVは、幅広い細菌に対する効率性、材料適合性、手の届かない場所への到達能力により人気を集めています。メーカー各社は、携帯可能で使い勝手の良いHPV消毒装置の開発に注力しています。

製薬産業におけるバイオ除染の需要拡大：製薬事業は、製造施設、設備、完成品の無菌性を確保するためのバイオ除染技術の主要ユーザーです。生物製剤や先進的医薬品の増加により、効果的な洗浄技術への需要が高まっています。

ヘルスケアにおける予防対策と感染制御への注目の高まり：ヘルスケア産業は、医療関連感染（HAI）の数を減らすため、予防対策と感染制御に注力しています。バイオ除染は、病院、特に重症治療室や手術室の無菌環境を維持するために不可欠です。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主要調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 バイオ汚染除去市場：製品別

• 機器
• 消耗品

第5章 バイオ汚染除去市場：薬剤別

• 過酸化水素
• 二酸化塩素
• 過酢酸
• 二酸化窒素

第6章 バイオ汚染除去市場：タイプ別

• チャンバー除染
• ルーム除染

第7章 バイオ汚染除去市場：エンドユーザー別

• 医薬品・医療機器メーカー
• 受託製造・研究機関
• 病院ヘルスケア施設
• その他

第8章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第9章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第10章 競合情勢

• 主要企業
• 市場シェア分析

第11章 企業プロファイル

• STERIS（米国）
• Bioquell（Ecolab）（英国）
• JCE BIoTechnology（フランス）
• Fedegari Autoclavi S.p.A.（イタリア）
• TOMI Environmental Solutions, Inc.（米国）

第12章 市場展望市場展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第13章 付録

• 略語リスト
• 供給源と参考文献

Bio Decontamination Market Size and Forecast

Bio Decontamination Market size was valued at USD 149.83 Million in 2024 and is projected to reach USD 208.54 Million by 2032, growing at a CAGR of 4.22% from 2026 to 2032.

Bio decontamination is the process of eliminating or lowering microbial contamination to a tolerable level. It is critical in a variety of settings where the presence of germs might offer serious health hazards.

Bio decontamination is used in hospital environments such as isolation rooms, critical care units, and operating theaters to avoid the transmission of pathogens.

Furthermore, it is also utilized in pharmaceutical and biotechnology companies to ensure product purity and employee safety.

Global Bio Decontamination Market Dynamics

The key market dynamics that are shaping the bio decontamination market include:

Key Market Drivers

Increasing Healthcare-Associated Infections (HAIs): The increased number of HAIs is a primary driver of the bio decontamination market. According to the Centers for Disease Control and Prevention (CDC), one in every 31 hospital patients contracts at least one healthcare-associated infection on any given day. This high incidence highlights the crucial need for robust bio decontamination solutions in healthcare settings to limit the spread of illnesses and ensure patient safety.

Growing Pharmaceutical and Biotechnology Industries: The growth of the pharmaceutical and biotechnology industries is increasing the demand for bio decontamination services and products. The FDA reported that 37 innovative medications were approved in 2022, demonstrating the industry's ongoing expansion and innovation. This rise is directly related to an increased demand for sterile industrial environments and contamination control methods, which is driving the bio decontamination market.

Stringent Regulatory Standards: Stricter restrictions on cleanliness and sterility in many industries are driving the bio decontamination market ahead. For instance, the European Medicines Agency (EMA) implemented EU GMP Annex 1 in August 2024, which establishes detailed rules for the production of sterile medical goods. This rule highlights the necessity of contamination control measures, which encourages the use of sophisticated bio decontamination technology and services.

Key Challenges:

High Cost: The high cost of bio decontamination technologies and services, including the initial investment in equipment and infrastructure, restricts uptake, particularly in resource-constrained settings and developing countries. This cost barrier prevents the widespread adoption of these crucial decontamination methods.

Lack of Awareness: In some locations, there is a lack of awareness regarding the importance and benefits of bio decontamination, resulting in lower adoption rates. Educating end users and stressing the importance of keeping clean and sanitary settings is critical for overcoming this constraint.

Variability in Pathogen Resistance: Different infections' resistance levels affect the efficacy of bio decontamination procedures, making it difficult to ensure consistent and accurate decontamination results. Addressing this variability is critical to the market's continued development.

Key Trends:

Increasing Adoption of Hydrogen Peroxide Vapor (HPV) Technology: HPV is gaining popularity due to its efficiency against a wide spectrum of germs, material compatibility, and ability to reach inaccessible locations. Manufacturers are concentrating on creating portable and user-friendly HPV disinfection equipment.

Growing Demand for Bio Decontamination in the Pharmaceutical Industry: The pharmaceutical business is a major user of bio decontamination technology to ensure the sterility of manufacturing facilities, equipment, and finished goods. The growth of biologics and sophisticated medicines is increasing the demand for effective cleaning technologies.

Increasing Focus on Preventive Measures and Infection Control in Healthcare: The healthcare industry is focusing on preventative measures and infection control to lower the number of healthcare-associated infections (HAIs). Bio decontamination is vital for maintaining a sterile environment in hospitals, particularly critical care units and operating rooms.

Global Bio Decontamination Market Regional Analysis

Here is a more detailed regional analysis of the bio decontamination market:

North America:

According to Verified Market Research, North America is estimated to dominate during the forecast period. North America, particularly the United States, leads in healthcare spending, resulting in increased investment in advanced bio decontamination technologies. According to the Centers for Medicare & Medicaid Services (CMS), U.S. healthcare spending will total $4.3 trillion in 2021, accounting for 18.3% of the country's GDP. This significant investment promotes the use of cutting-edge bio decontamination solutions in healthcare facilities throughout the region.

North America has some of the strictest rules for cleanliness and sterility in healthcare and pharmaceutical facilities. The United States Food and Medication Administration (FDA) said that in fiscal year 2022, it conducted over 3,000 inspections of human medication manufacturing plants to ensure compliance with good manufacturing standards. This regulatory pressure promotes the market for effective bio-decontamination goods and services to meet these high standards.

Furthermore, North America has a large biotechnology and pharmaceutical industry, which necessitates severe bio decontamination protocols. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), the US biopharmaceutical industry invested an estimated $102.3 billion in research and development in 2021. This significant investment and expansion in the sector is directly related to an increased demand for bio decontamination solutions to maintain sterile research and manufacturing environments.

Asia Pacific:

The Asia Pacific region is estimated to exhibit the highest growth during the forecast period. The Asia Pacific region is rapidly expanding its healthcare facilities, resulting in increased demand for bio decontamination services and goods. According to the Asian Development Bank, healthcare spending in the Asia-Pacific region is expected to reach USD 2.4 Trillion by 2032, expanding at a CAGR of 6.3% between 2014 and 2032. This significant investment in healthcare infrastructure demands cutting-edge bio decontamination solutions to maintain sterile surroundings and avoid illness.

The increased incidence of HAIs in the region is a significant driver of the bio decontamination market. According to a study published in the Lancet Global Health, the prevalence of HAIs in Southeast Asia is over 9.0%, much higher than the global average of 7.6%. The high incidence emphasizes the urgent need for effective bio decontamination measures in healthcare settings across the Asia Pacific region.

Furthermore, the fast growth of the pharmaceutical and biotechnology sectors in the Asia Pacific is driving up demand for bio decontamination products and services. According to the India Brand Equity Foundation (IBEF), the Indian pharmaceutical sector alone is anticipated to be worth USD 130 Billion by 2032, increasing at a 12.3% CAGR. Similarly, McKinsey & Company estimates that China's pharmaceutical market would approach USD $300 Billion by 2025. This exponential rise in these industries needs strict contamination control methods, which is driving the regional bio decontamination market.

Europe:

Europe region is estimated to exhibit substantial growth during the forecast period. Europe's aging population is increasing the demand for healthcare services, which in turn raises the demand for bio decontamination in medical institutions. According to Eurostat, the proportion of adults 65 and older in the EU is expected to rise from 20.8% in 2021 to 31.3% by 2100. This demographic transition is projected to increase hospital admissions and medical treatments, needing strict bio decontamination measures to prevent healthcare-associated infections.

Europe has enacted stringent cleanliness and sterility rules in a variety of industries, most notably healthcare and pharmaceuticals. For example, the European Union's Good Manufacturing Practice (GMP) guidelines, which include the recently amended Annex 1 for sterile pharmaceutical products, establish stringent contamination control requirements. The European Medicines Agency (EMA) reported that in 2022, it recommended 89 medicines for marketing authorization, all of which must comply with these stringent bio decontamination standards.

Furthermore, Europe has a booming pharmaceutical and biotechnology industry, which is a major driver of the bio decontamination market. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the pharmaceutical industry invested around €44.5 billion in R&D in Europe in 2022. This significant investment in R&D demands modern bio decontamination solutions to provide sterile environments for medication development and manufacturing activities.

Global Bio Decontamination Market: Segmentation Analysis

The Bio Decontamination Market is segmented based on Product, Type, Agent, End-User, and Geography.

Bio Decontamination Market, By Product

• Equipment
• Consumables

Based on Product, the market is segmented into Equipment and Consumables. The equipment segment is estimated to dominate the bio decontamination market. This segment includes devices like hydrogen peroxide vaporizers, chlorine dioxide generators, and peracetic acid systems, which are essential for disinfecting and sterilizing surfaces, equipment, and environments in a variety of industries, including healthcare, pharmaceuticals, and biotechnology. The increased demand for this equipment reflects the growing requirement for effective bio-decontamination solutions to minimize illness transmission and assure product safety.

Bio Decontamination Market, By Type

• Chamber Decontamination
• Room Decontamination

Based on Type, the Bio Decontamination market is segmented into Chamber Decontamination and Room Decontamination. The chamber decontamination segment is estimated to dominate the market over the forecast period due to the widespread adoption of chamber-based bio decontamination systems in pharmaceutical, biotechnology, and research laboratories. These enclosed chambers provide regulated and effective decontamination of equipment, tools, and other key infrastructure, making them the ideal method for maintaining sterile workplaces in high-risk industries.

Bio Decontamination Market, By Agent

• Hydrogen Peroxide
• Chlorine Dioxide
• Peracetic Acid
• Nitrogen Dioxide

Based on Agent, the market is divided into Hydrogen Peroxide, Chlorine Dioxide, Peracetic Acid, and Nitrogen Dioxide. The hydrogen peroxide segment is estimated to dominate the global market. Hydrogen peroxide is used because it is efficient against a wide range of microorganisms, including spores, and may permeate surfaces and equipment. The advantages of hydrogen peroxide over other agents, such as its quick action, low toxicity, and ease of monitoring, are responsible for the segment's dominance in the bio decontamination market.

Bio Decontamination Market, By End-User

• Pharmaceutical and Medical Device Manufacturers
• Contract Manufacturing and Research Organizations
• Hospital and Healthcare Facilities
• Others

Based on End-User, the market is segmented into Pharmaceutical & Medical Device Manufacturers, Contract Manufacturing & Research Organizations, Hospital & Healthcare Facilities, and Others. The pharmaceutical & medical device manufacturers segment is estimated to dominate this segment in the forecast period due to the strict regulatory standards imposed by agencies, which need cleaning and sterilizing operations to prevent product contamination. The growing frequency of product recalls due to contamination issues has spurred the use of bio decontamination solutions by pharmaceutical and medical device makers to maintain product quality and safety.

Bio Decontamination Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the bio decontamination market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America is estimated to dominate the bio decontamination market during the forecast period due to the healthcare sector's rapid expansion, rising occurrences of hospital-acquired illnesses, an aging population, and increased government programs and investments in healthcare facility sanitation.

Key Players

• The "Bio Decontamination Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are STERIS (U.S.), Bioquell (Ecolab) (U.K.), JCE Biotechnology (France), Fedegari Autoclavi S.p.A. (Italy), and TOMI Environmental Solutions, Inc. (U.S.).

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Bio Decontamination Market Recent Developments
• In July 2024, Ecolab's Bioquell HPV-AQ was granted authorization for use in all European Union and European Economic Area territories.
• In December 2024, TOMI Environmental Solutions, Inc. introduced new SteraMist products, including the Select Plus, a hybrid solution that combines the company's current Surface Select and Environment systems.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Bio Decontamination Market, By Product

• Equipment
• Consumables

5. Bio Decontamination Market, By Agent

• Hydrogen Peroxide
• Chlorine Dioxide
• Peracetic Acid
• Nitrogen Dioxide

6. Bio Decontamination Market, By Type

• Chamber Decontamination
• Room Decontamination

7. Bio Decontamination Market, By End User

• Pharmaceutical and Medical Device Manufacturers
• Contract Manufacturing and Research Organizations
• Hospital and Healthcare Facilities
• Others

8. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

9. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

10. Competitive Landscape

• Key Players
• Market Share Analysis

11. Company Profiles

• STERIS (U.S.)
• Bioquell (Ecolab) (U.K.)
• JCE Biotechnology (France)
• Fedegari Autoclavi S.p.A. (Italy)
• TOMI Environmental Solutions, Inc. (U.S.)

12. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

13. Appendix

• List of Abbreviations
• Sources and References